IBDEI3BW ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,2232,0)
 ;;=ESTABLISHED PATIENT^1^168
 ;;^UTILITY(U,$J,358.4,2233,0)
 ;;=CONSULTATIONS^2^168
 ;;^UTILITY(U,$J,358.4,2234,0)
 ;;=TELEHEALTH FACILITY FEE^1^169
 ;;^UTILITY(U,$J,358.4,2235,0)
 ;;=A DIAGNOSES^1^170
 ;;^UTILITY(U,$J,358.4,2236,0)
 ;;=D DIAGNOSES^4^170
 ;;^UTILITY(U,$J,358.4,2237,0)
 ;;=E DIAGNOSES^5^170
 ;;^UTILITY(U,$J,358.4,2238,0)
 ;;=F DIAGNOSES^6^170
 ;;^UTILITY(U,$J,358.4,2239,0)
 ;;=I DIAGNOSES^9^170
 ;;^UTILITY(U,$J,358.4,2240,0)
 ;;=K DIAGNOSES^10^170
 ;;^UTILITY(U,$J,358.4,2241,0)
 ;;=M DIAGNOSES^12^170
 ;;^UTILITY(U,$J,358.4,2242,0)
 ;;=N DIAGNOSES^13^170
 ;;^UTILITY(U,$J,358.4,2243,0)
 ;;=P DIAGNOSES^15^170
 ;;^UTILITY(U,$J,358.4,2244,0)
 ;;=R DIAGNOSES^16^170
 ;;^UTILITY(U,$J,358.4,2245,0)
 ;;=S DIAGNOSES^17^170
 ;;^UTILITY(U,$J,358.4,2246,0)
 ;;=T DIAGNOSES^19^170
 ;;^UTILITY(U,$J,358.4,2247,0)
 ;;=V DIAGNOSES^21^170
 ;;^UTILITY(U,$J,358.4,2248,0)
 ;;=X DIAGNOSES^23^170
 ;;^UTILITY(U,$J,358.4,2249,0)
 ;;=C DIAGNOSES^3^170
 ;;^UTILITY(U,$J,358.4,2250,0)
 ;;=W DIAGNOSES^22^170
 ;;^UTILITY(U,$J,358.4,2251,0)
 ;;=B DIAGNOSES^2^170
 ;;^UTILITY(U,$J,358.4,2252,0)
 ;;=G DIAGNOSES^7^170
 ;;^UTILITY(U,$J,358.4,2253,0)
 ;;=H DIAGNOSES^8^170
 ;;^UTILITY(U,$J,358.4,2254,0)
 ;;=L DIAGNOSES^11^170
 ;;^UTILITY(U,$J,358.4,2255,0)
 ;;=O DIAGNOSES^14^170
 ;;^UTILITY(U,$J,358.4,2256,0)
 ;;=U DIAGNOSES^20^170
 ;;^UTILITY(U,$J,358.4,2257,0)
 ;;=Z DIAGNOSES^24^170
 ;;^UTILITY(U,$J,358.4,2258,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^18^170
 ;;^UTILITY(U,$J,358.4,2259,0)
 ;;=TELEHEALTH FACILITY FEE^1^171
 ;;^UTILITY(U,$J,358.4,2260,0)
 ;;=INFECTIOUS DISEASE^12^172
 ;;^UTILITY(U,$J,358.4,2261,0)
 ;;=NEOPLASMS^14^172
 ;;^UTILITY(U,$J,358.4,2262,0)
 ;;=HEMATOLOGY/ENDOCRINE^9^172
 ;;^UTILITY(U,$J,358.4,2263,0)
 ;;=MENTAL HEALTH^13^172
 ;;^UTILITY(U,$J,358.4,2264,0)
 ;;=NEUROLOGY^15^172
 ;;^UTILITY(U,$J,358.4,2265,0)
 ;;=GI^7^172
 ;;^UTILITY(U,$J,358.4,2266,0)
 ;;=CARDIOLOGY^3^172
 ;;^UTILITY(U,$J,358.4,2267,0)
 ;;=HERNIA^10^172
 ;;^UTILITY(U,$J,358.4,2268,0)
 ;;=GENITOURINARY^6^172
 ;;^UTILITY(U,$J,358.4,2269,0)
 ;;=SKIN^22^172
 ;;^UTILITY(U,$J,358.4,2270,0)
 ;;=ENT^4^172
 ;;^UTILITY(U,$J,358.4,2271,0)
 ;;=RHEUMATOLOGY/ORTHO^20^172
 ;;^UTILITY(U,$J,358.4,2272,0)
 ;;=RESPIRATORY^19^172
 ;;^UTILITY(U,$J,358.4,2273,0)
 ;;=SIGNS/SYMPTOMS/HX OF^21^172
 ;;^UTILITY(U,$J,358.4,2274,0)
 ;;=VASCULAR^24^172
 ;;^UTILITY(U,$J,358.4,2275,0)
 ;;=ANTICOAGULATION^2^172
 ;;^UTILITY(U,$J,358.4,2276,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^23^172
 ;;^UTILITY(U,$J,358.4,2277,0)
 ;;=ALLERGY/ASTHMA^1^172
 ;;^UTILITY(U,$J,358.4,2278,0)
 ;;=EYES^5^172
 ;;^UTILITY(U,$J,358.4,2279,0)
 ;;=HEADACHES^8^172
 ;;^UTILITY(U,$J,358.4,2280,0)
 ;;=IMMUNOLOGY^11^172
 ;;^UTILITY(U,$J,358.4,2281,0)
 ;;=NICOTINE DEPENDENCE^16^172
 ;;^UTILITY(U,$J,358.4,2282,0)
 ;;=PERSONAL HX/STATUS^18^172
 ;;^UTILITY(U,$J,358.4,2283,0)
 ;;=COMMON DIAGNOSES^1^173
 ;;^UTILITY(U,$J,358.4,2284,0)
 ;;=BODY MASS INDEX^3^173
 ;;^UTILITY(U,$J,358.4,2285,0)
 ;;=OBESITY^4^173
 ;;^UTILITY(U,$J,358.4,2286,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^5^173
 ;;^UTILITY(U,$J,358.4,2287,0)
 ;;=ANTICOAGULATION^2^173
 ;;^UTILITY(U,$J,358.4,2288,0)
 ;;=MD/NP/PA ^1^174
 ;;^UTILITY(U,$J,358.4,2289,0)
 ;;=RN/LPN/SW/OTH HC PROF^2^174
 ;;^UTILITY(U,$J,358.4,2290,0)
 ;;=PROLONGED SVC-MD/NP/PA^3^174
 ;;^UTILITY(U,$J,358.4,2291,0)
 ;;=TELERETINAL PROCEDURES^1^175
 ;;^UTILITY(U,$J,358.4,2292,0)
 ;;=LOW VISION / BLINDNESS^21^176
